Articles related to TELEHEALTH

The DEA and HHS have extended telehealth prescribing flexibilities through December 31, 2024. This critical service allows for continued prescribing of controlled medications via virtual practice, addressing a significant need for many patients with mental health conditions and substance use disorders.

The transition to virtual models of care has introduced complexities in efficient handover between inpatient inits (IPUs) and virtual models of care. This shift necessitates proactive management of specific medication safety risks to ensure patient safety.

The study provides valuable insights into the use of telemedicine in primary care settings. It found that while telemedicine was used in over half of the primary care visits studied, these visits led to somewhat higher rates of in-person return visits compared to in-person primary care visits. This highlights the need for further research into optimizing telemedicine use.

Discover how telemedicine is reshaping healthcare across various specialties and how you can leverage it for better patient care.

The DEA’s upcoming guidelines could reshape how controlled substances are prescribed via telehealth. Stay informed and consider participating in the DEA’s listening sessions to ensure your practice adapts smoothly.

Dr. Marc Agronin discusses the evolving landscape of telepsychiatry, emphasizing its potential and challenges, especially for the elderly.